Clinical Trial

Published on 16 Oct 2023

Pembrolizumab and trastuzumab in combination with FLOT in the perioperative treatment of HER2-positive, localized esophagogastric adenocarcinoma—a phase II trial of the AIO study group (AIO STO 0321)

in Gastrointestinal Cancers: Gastric and Esophageal Cancers

Joseph Tintelnot
Alexander Stein
Salah-Eddin Al-Batran
Thomas Ettrich
Thorsten Götze
Barbara Grün
Georg Martin Haag
Vera Heuer
Ralf-Dieter Hofheinz
Nils Homann

Frontiers in Oncology

doi 10.3389/fonc.2023.1272175

3,117 views
4 citations

Original Research

Published on 10 Oct 2023

Involved-field irradiation or elective-nodal irradiation in neoadjuvant chemo-radiotherapy for locally-advanced esophageal cancer: comprehensive analysis for dosimetry, treatment-related complications, impact on lymphocyte, patterns of failure and survival

in Gastrointestinal Cancers: Gastric and Esophageal Cancers

Xianyan Chen
Yingjie Zhang
Xiaojuan Zhou
Min Wang
Feifei Na
Lin Zhou
Yong Xu
Bingwen Zou
Jianxin Xue
Yongmei Liu

Frontiers in Oncology

doi 10.3389/fonc.2023.1274924

1,639 views
2 citations

Original Research

Published on 09 Oct 2023

Efficacy and safety of zolbetuximab for first-line treatment of advanced Claudin 18. 2-positive gastric or gastro-esophageal junction adenocarcinoma: a systematic review and meta-analysis of randomized controlled trials

in Gastrointestinal Cancers: Gastric and Esophageal Cancers

Zhanpeng Liang
Liwen Liu
Wenxia Li
Huiqin Lai
Luzhen Li
Jiaming Wu
Huatang Zhang
Cantu Fang

Frontiers in Oncology

doi 10.3389/fonc.2023.1258347

6,660 views
3 citations

Original Research

Published on 06 Oct 2023

Development of a deep learning model for early gastric cancer diagnosis using preoperative computed tomography images

in Gastrointestinal Cancers: Gastric and Esophageal Cancers

Zhihong Gao
Zhuo Yu
Xiang Zhang
Chun Chen
Zhifang Pan
Xiaodong Chen
Weihong Lin
Jun Chen
Qichuan Zhuge
Xian Shen

Frontiers in Oncology

doi 10.3389/fonc.2023.1265366

3,103 views
1 citation

Original Research

Published on 03 Oct 2023

Clinical outcomes and risk factors of non-curative endoscopic submucosal dissection for early gastric cancer: a retrospective multicenter study in Zhejiang, China

in Gastrointestinal Cancers: Gastric and Esophageal Cancers

Chao-qiong Jin
Jing Zhao
Xiao-yun Ding
Liang-liang Yu
Guo-liang Ye
Xin-jian Zhu
Jian-wei Shen
Ye Yang
Bo Jin
Chun-li Zhang

Frontiers in Oncology

doi 10.3389/fonc.2023.1225702

1,551 views
1 citation

Systematic Review

Published on 02 Oct 2023

Prognostic role of preoperative lymphocyte/C-reactive protein associated with upper gastrointestinal cancer: a meta-analysis

in Gastrointestinal Cancers: Gastric and Esophageal Cancers

Yongjuan Ye
Guozhi Wu
Hao Yuan
Ya Zheng
Yuping Wang
Qinghong Guo

Frontiers in Oncology

doi 10.3389/fonc.2023.1181649

1,143 views
1 citation

Original Research

Published on 02 Oct 2023

Endoscopic characteristics and high-risk background mucosa factors of early gastric cancer after helicobacter pylori eradication: a single-center retrospective study

in Gastrointestinal Cancers: Gastric and Esophageal Cancers

Yali Wei
Congcong Min
Chongguang Zhao
Yubei Li
Xiaowei Wang
Xue Jing
Yanan Yu
Xiaoyu Li
Xiaoyan Yin

Frontiers in Oncology

doi 10.3389/fonc.2023.1272187

1,538 views
1 citation

Review

Published on 29 Sep 2023

The role of microbiota in the development and treatment of gastric cancer

in Gastrointestinal Cancers: Gastric and Esophageal Cancers

Yiwen Wang
Wenjie Han
Na Wang
Mengzhen Han
Meng Ban
Jianying Dai
Yuesheng Dong
Tao Sun
Junnan Xu

Frontiers in Oncology

doi 10.3389/fonc.2023.1224669

6,020 views
8 citations

Clinical Trial

Published on 29 Sep 2023

Study protocol of a phase II clinical trial evaluating the efficacy of neoadjuvant intraperitoneal and systemic albumin-bound paclitaxel combined with camrelizumab and S-1 in the treatment of patients with exfoliative cell-positive gastric cancer

in Gastrointestinal Cancers: Gastric and Esophageal Cancers

Jingxia Lv
Jiaxiang Wu
Haotian Wu
Ping’an Ding
Honghai Guo
Peigang Yang
Yuan Tian
Yang Liu
Qun Zhao

Frontiers in Oncology

doi 10.3389/fonc.2023.1201928

2,150 views

Original Research

Published on 22 Sep 2023

Postoperative serum squamous cell carcinoma antigen and carcinoembryonic antigen predict overall survival in surgical patients with esophageal squamous cell carcinoma

in Gastrointestinal Cancers: Gastric and Esophageal Cancers

Yi Huang
Fangfang Liu
Ruiping Xu
Fuyou Zhou
Wenlei Yang
Yu He
Zhen Liu
Bolin Hou
Linlin Liang
Lixin Zhang

Frontiers in Oncology

doi 10.3389/fonc.2023.1263990

1,713 views
1 citation

Systematic Review

Published on 21 Sep 2023

Frailty and long-term survival of patients with gastric cancer: a meta-analysis

in Gastrointestinal Cancers: Gastric and Esophageal Cancers

Hongliang Liang
Aiping Hu

Frontiers in Oncology

doi 10.3389/fonc.2023.1239781

1,719 views
3 citations

Systematic Review

Published on 15 Sep 2023

Circulating ghrelin levels in patients with gastric cancer: a systematic review and meta-analysis

in Gastrointestinal Cancers: Gastric and Esophageal Cancers

Yuxuan Wang
Caishun Zhang
Jiaqing Yu
Qing Zhang
Yukai Wang
Yunqiu Xia
Jing Dong

Frontiers in Oncology

doi 10.3389/fonc.2023.1255112

1,568 views
1 citation

Systematic Review

Published on 14 Sep 2023

Risk factors for metachronous esophageal squamous cell carcinoma after endoscopic or surgical resection of esophageal carcinoma: a systematic review and meta-analysis

in Gastrointestinal Cancers: Gastric and Esophageal Cancers

Jie Du
Zhixian Bao
Tianhu Liang
Hongmei Zhao
Junxian Zhao
Ruipu Xu
Xiaohui Wang

Frontiers in Oncology

doi 10.3389/fonc.2023.1241572

1,609 views
2 citations

Original Research

Published on 12 Sep 2023

Predictive value of DNA methylation in the efficacy of chemotherapy for gastric cancer

in Gastrointestinal Cancers: Gastric and Esophageal Cancers

Ye Li
Ning Mo
Dong Yang
QiuLu Lin
WenFeng Huang
Rensheng Wang

Frontiers in Oncology

doi 10.3389/fonc.2023.1238310

1,871 views
1 citation

Original Research

Published on 06 Sep 2023

Transcatheter arterial chemoembolization combined with apatinib and camrelizumab for unresectable advanced gastric or gastroesophageal junction cancer: a single-arm, single-center, retrospective study

in Gastrointestinal Cancers: Gastric and Esophageal Cancers

Kunpeng Wu
Yahua Li
Zongming Li
Zihe Zhou
Xiaoyong Ge
Yifan Li
Xinwei Han
Peng Chen
Kewei Ren

Frontiers in Oncology

doi 10.3389/fonc.2023.1143578

2,780 views
2 citations

Original Research

Published on 04 Sep 2023

Methodological quality of radiomic-based prognostic studies in gastric cancer: a cross-sectional study

in Gastrointestinal Cancers: Gastric and Esophageal Cancers

Tianxiang Jiang
Zhou Zhao
Xueting Liu
Chaoyong Shen
Mingchun Mu
Zhaolun Cai
Bo Zhang

Frontiers in Oncology

doi 10.3389/fonc.2023.1161237

1,556 views

Navigation group

Articles

Pembrolizumab and trastuzumab in combination with FLOT in the perioperative treatment of HER2-positive, localized esophagogastric adenocarcinoma—a phase II trial of the AIO study group (AIO STO 0321)

Involved-field irradiation or elective-nodal irradiation in neoadjuvant chemo-radiotherapy for locally-advanced esophageal cancer: comprehensive analysis for dosimetry, treatment-related complications, impact on lymphocyte, patterns of failure and survival

Efficacy and safety of zolbetuximab for first-line treatment of advanced Claudin 18. 2-positive gastric or gastro-esophageal junction adenocarcinoma: a systematic review and meta-analysis of randomized controlled trials

Development of a deep learning model for early gastric cancer diagnosis using preoperative computed tomography images

Clinical outcomes and risk factors of non-curative endoscopic submucosal dissection for early gastric cancer: a retrospective multicenter study in Zhejiang, China

Prognostic role of preoperative lymphocyte/C-reactive protein associated with upper gastrointestinal cancer: a meta-analysis

Endoscopic characteristics and high-risk background mucosa factors of early gastric cancer after helicobacter pylori eradication: a single-center retrospective study

The role of microbiota in the development and treatment of gastric cancer

Study protocol of a phase II clinical trial evaluating the efficacy of neoadjuvant intraperitoneal and systemic albumin-bound paclitaxel combined with camrelizumab and S-1 in the treatment of patients with exfoliative cell-positive gastric cancer

Postoperative serum squamous cell carcinoma antigen and carcinoembryonic antigen predict overall survival in surgical patients with esophageal squamous cell carcinoma

Frailty and long-term survival of patients with gastric cancer: a meta-analysis

Circulating ghrelin levels in patients with gastric cancer: a systematic review and meta-analysis

Risk factors for metachronous esophageal squamous cell carcinoma after endoscopic or surgical resection of esophageal carcinoma: a systematic review and meta-analysis

Predictive value of DNA methylation in the efficacy of chemotherapy for gastric cancer

Transcatheter arterial chemoembolization combined with apatinib and camrelizumab for unresectable advanced gastric or gastroesophageal junction cancer: a single-arm, single-center, retrospective study

Methodological quality of radiomic-based prognostic studies in gastric cancer: a cross-sectional study